top of page
Search

Clinical Study Confirms Somnoril™ Enhances Sleep, Weight Management, Mood, and Reduces Food Cravings

Fairfield, CA – October 14, 2024 – Somnoril™, a branded dietary supplement ingredient from Gateway Health Alliances, has been shown to significantly reduce food cravings, support weight loss, improve mood, reduce stress, and enhance overall quality of life, according to recent clinical findings published in the Journal of Dietary Supplements.

 

This publication marks the second paper from a randomized, double-blind, placebo-controlled study of the patented extract of Dichrostachys glomerata, a West African spice rich in bioactive compounds, including flavonoids, polyphenols, alkaloids, tannins, saponins, and terpenoids. The study was conducted by researchers at Jacksonville University, Wellness Discovery Labs, and the University of North Florida.

 

“This is an important study that expands the known benefits of this remarkable natural food ingredient,” said Heather A. Hausenblas, Ph.D., lead study author and Professor, School of Applied Health Sciences, Brooks Rehabilitation College of Healthcare Sciences at Jacksonville University. “In addition to weight management, Dichrostachys glomerata supports other aspects of physical and mental health and wellness.”

 

Previous Findings

The initial paper highlighted Somnoril’s role in improving sleep quality, promoting healthy weight loss, and enhancing metabolic wellness. Key benefits included faster sleep onset, longer sleep duration, and improved wakefulness, contributing to better daytime activity. The 60-day study involved 56 participants aged 25-60 (median age 44) with an average BMI of 31.66 who experienced poor sleep. Participants were given either a placebo or 300 mg of Somnoril daily.

 

New Findings on Weight Management and Quality of Life

The latest paper expands on Somnoril’s weight management benefits and its impact on overall quality of life in overweight and mildly obese adults. The study’s analysis at Baseline (Day 0), Day 30, and Day 60 used validated measurement tools to evaluate the effects of Somnoril on weight, mood, food cravings, anxiety, stress, and overall health.

 

Key Results:

 

  • Significant Weight Loss: Participants taking Somnoril lost an average of 4.11 lbs. compared to 2.19 lbs. in the placebo group (p = .05 at Day 60).

 

  • Reduced Food Cravings: A significant reduction in food cravings was observed in the Somnoril group at both 30 and 60 days (p < .001). Food cravings were measured using the Food Cravings Questionnaire, a validated six-point self-reporting tool.

 

  • Improved Mood and Reduced Stress: The study demonstrated a significant improvement in mood and reduction in perceived stress levels among participants taking Somnoril (p < .001). A notable decrease in anxiety was also observed.

 

  • Enhanced Health-Related Quality of Life: Participants taking Somnoril experienced significant improvements in their overall health, physical and mental well-being (p < .01), and fewer disruptions to their daily lives due to health issues compared to the placebo group (p < .05).

 

A Compelling Body of Clinical Evidence

Six randomized, placebo-controlled, and peer-reviewed clinical studies involving over 600 participants have demonstrated the efficacy of Dichrostachys glomerata in managing body weight, enhancing metabolic balance, and improving sleep. Somnoril works by modulating key hormones, including GLP-1, insulin, leptin, and adiponectin, while reducing oxidative stress.

 

About Gateway Health Alliances

Gateway Health Alliances partners with food, beverage, and supplement manufacturers worldwide, offering natural, science-based ingredients designed to support effective weight management. Established in 2005, Gateway is committed to the discovery and development of ingredient solutions that enhance overall health and well-being. Gateway’s branded ingredients, protected by more than 25 patents, support healthy weight management, cardiovascular health, metabolic wellness, and blood sugar balance.

 

The company also markets other Dichrostachys glomerata products for weight loss under the brand names Dyglomera® and DygloFit®.

 

All Gateway ingredients are sustainably sourced, manufactured according to high-quality standards, and validated for purity and authenticity through Purity IQ and other quantitative analytical methods.

 

 

コメント


bottom of page